Prevention Flashcards
(152 cards)
COPD diagnosis, look at FEV1/FVC. Obstructive lung disease present at less than __% when compared to others
70%
Tertiary prevention for COPD is to
Get patient to stop smoking
3rd leading cause of death in the world is:
COPD
2nd leading cause of death in the world is:
Stroke
1st leading cause of death in the world is:
Ischemic heart disease
After quitting smoking, HR normalizes after __ minutes, CO levels normalize after __ hours, risk of MI falls and lung function returns to normal curve after __-__ weeks, risk of CAD is 50% that of a smoker after __ year(s).
20 minutes
12 hours
2 - 12 weeks
1 year
Symptoms of nicotine withdrawal
Depression, insomnia, irritability, anxiety, impaired concentration, appetite changes
Smoking cessation can involve behavioral counseling, as well as (4) described alternative therapies:
Acupuncture, aversive therapy, financial incentive from employers, hypnosis
Five A’s of smoking cessation:
Ask (about use every visit) Advise (quitting) Assess (willingness) Assist (in attempt to quit) Arrange (follow up)
7 options recognized by USPHS for smoking cessation:
Nicotine patch, gum, lozenge, inhaler, nasal spray
Bupropion
Varenicline
Action of bupropion
Enhances CNS release of dopamine
Action of Varenicline
Partial agonist of a4-B2 nicotine content acetylcholine receptor
Medications to limit disability of COPD
Short acting beta agonists (albuterol, lee albuterol)
Anticholinergics (ipratroium)
Long acting beta agonists
Long acting anticholinergics/antimuscarinics (tiotropium)
Corticosteroids
Best: LABA, LAMA, ICS combination
PDE-4 inhibitors
Theophylline
supplemental O2
Pneumococcal and influenza vaccinations
Supplemental oxygen improves survival for COPD for patients and is recommended for those with:
RA pulse ox less than 88%
PaO2 less than 55mmHg on RA
PaO2 less than 60mmHg with for pulmonary or polycythemia
Pulmonary rehab indicated in moderate to severe COPD and benefits may last up to:
18 months after rehab
Lung Volume Reduction Surgery provided survival advantage for COPD patients with:
Upper lobe emphysema and low exercise capacity
Some increased mortality
Lung transplant for COPD patients improves FC and should be considered in patients with:
Post-bronchodilator FEV1 less than 25% predicted
Resting hypoxemia
Hypercapnia
Pulmonary HTN
Diagnosing asthma with bronchodilator, FEV1 improves:
More than 15%
Diagnosing asthma, methocholine challenge drops FEV1:
More than 20%
Tertiary prevention for asthma involves:
Avoiding triggers and preventing or treating exacerbation a
Persistent moderate asthma:
exhibits symptoms _______
Night time awakenings _______
Short acting beta agonist _________
Interferes with normal activity _________
Lung function FEV1 is between __% and __%
Daily More than once a week Daily Some limitation 60% and 80%
Steps 1 - 6 for intermittent thru persistent asthma treatment:
1) SABA PRN
2) low dose inhaled glucocorticoids
3) 2 plus LABA or medium dose
4) medium dose glucocorticoid plus LABA
5) high dose glucocorticoid plus LABA and maybe omalizumab if allergies present
6) high dose glucocorticoid, LABA, oral systemic glucocorticoid.
Healthcare practitioners collect data on a single patient, epidemiologists:
Collect data on an entire population
Classical epidemiology: population oriented. Interested in:
Risk factors that can be altered to prevent or delay disease,min jury, and death.